Reducing pERKs to Break "RAS"istance to Sotorasib
- PMID: 40049766
- DOI: 10.1016/j.jtho.2025.01.002
Reducing pERKs to Break "RAS"istance to Sotorasib
Conflict of interest statement
Disclosure Drs. Gray and Mutti received a grant for an investigator-initiated study from Portage Biotech. Dr. Meirson reports receiving consulting fees from Purple Biotech. Dr. O’Connor declares no conflict of interest.
Publication types
LinkOut - more resources
Full Text Sources
